Press Releases from PATH Diagnostics
2023
WHO resolution on strengthening diagnostics capacity key for global progress
New panel of antibodies specific to SARS-CoV-2 variants available for vaccine researchers
2022
P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing
2021
New panel of antibodies available to support the development of affordable pneumococcal vaccines
STANDARD G6PD Test receives regulatory approval by the Australian Therapeutic Goods Administration
PATH and The University of Queensland create custom proteins for malaria diagnostics
PATH supports partners to use environmental surveillance to monitor the presence of COVID-19
2020
PATH and Wondfo partner to develop a point-of-care rapid diagnostic test for G6PD deficiency
PATH and partners develop and market environmental surveillance tool for polio eradication
Washington COVID-19 biorepository supports global quest for affordable diagnostics